Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 1.02% today. In the last week its performance is 8.83%, and 18.87% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 332.5, so today’s gain of 1.02% is a significant step towards its target price. The GAP today is therefore 0.51%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 68920.1, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.60%.
At the current price of 317.78, it has a dividend yield of *TBA, and its target price is 332.5. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 18.36, as well as a forward P/E of 15.12.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 3.32%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 9.01%.
Performance for the year is -6.22%. Since its IPO date on 9/17/1991, the total performance to date is 2.68%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 655673, while its average volume is 2079.06. Whilst the total gain today was 1.02%, it did have a day high of -4.76%.
Volatility for this week has been at 4.57%, and 2.57% for the month. The 52-week low for Biogen Inc., BIIB has been 42.49%, while the 52-week-high has reached -6.12%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.04, and the P/S is 6.13, along with a P/B of 6.04. Meanwhile it has a p/cash of 18.15.